Hyperammonemic encephalopathy in a patient receiving fluorouracil/oxaliplatin chemotherapy

Clin Case Rep. 2018 Feb 13;6(4):603-605. doi: 10.1002/ccr3.1422. eCollection 2018 Apr.

Abstract

Hyperammonemia is a rare adverse effect of 5-fluorouracil (5-FU) therapy, but can be very serious, even fatal. Physicians must be aware that hyperammonemic encephalopathy sometimes develops as an adverse event after 5-FU therapy.

Keywords: Chemotherapy; colon cancer; fluorouracil; hyperammonemia; mental disorder.

Publication types

  • Case Reports